Molecular Measurable Residual Disease Testing of Blood During AML Cytotoxic Therapy for Early Prediction of Clinical Response. uri icon

authors

  • Wong, Hong Yuen
  • Tang, Jingrong
  • Thompson, Julie
  • DeStefano, Christin B
  • Romero, Kristi
  • Dillon, Laura W
  • Kim, Dong-Yun
  • Lai, Catherine
  • Hourigan, Christopher S
  • Anthony Sung, MD
  • Lindblad, Katherine E
  • Sheela, Sheenu
  • Roloff, Gregory W
  • Rizzieri, David
  • Goswami, Meghali
  • Mulé, Matthew P
  • Ramos, Nestor R

publication date

  • January 1, 2019